• Contact

  • Newsletter

  • About us

  • Delivery options

  • Prospero Book Market Podcast

  • The Oxford Handbook of Opioids and Opioid Use Disorder

    The Oxford Handbook of Opioids and Opioid Use Disorder by Dunn, Kelly E.;

    Series: Oxford Library of Psychology;

      • GET 10% OFF

      • The discount is only available for 'Alert of Favourite Topics' newsletter recipients.
      • Publisher's listprice GBP 154.00
      • The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.

        73 573 Ft (70 070 Ft + 5% VAT)
      • Discount 10% (cc. 7 357 Ft off)
      • Discounted price 66 216 Ft (63 063 Ft + 5% VAT)

    73 573 Ft

    db

    Availability

    Estimated delivery time: In stock at the publisher, but not at Prospero's office. Delivery time approx. 3-5 weeks.
    Not in stock at Prospero.

    Why don't you give exact delivery time?

    Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.

    Product details:

    • Publisher OUP USA
    • Date of Publication 3 February 2025

    • ISBN 9780197618431
    • Binding Hardback
    • No. of pages1072 pages
    • Size 246x175x58 mm
    • Weight 1905 g
    • Language English
    • Illustrations 40 b/w illustrations
    • 634

    Categories

    Short description:

    The Oxford Handbook of Opioids and Opioid Use Disorder synthesizes research across the spectrum and establishes a foundational knowledge regarding historical and current epidemiological trends, neurobiological and genetic contributors to opioid effects and opioid use disorder (OUD), and core elements of opioid use such as withdrawal and craving. It also provides specific information and guidance regarding opioid treatment paradigms. This handbook will serve as a comprehensive guide for practitioners, policymakers, students, and researchers who wish to achieve a better understanding of the complex world of opioid and OUD practice and science.

    More

    Long description:

    Opioids have played a prominent role in society for centuries and have been lauded for both their analgesic and euphoric qualities by cultures throughout the world. The advent of medical and pharmaceutical sciences in the 20th century ushered in a wide variety of different commercial opioid products that were designed to maximize their therapeutic potential. As the use of opioids increased, a corresponding need emerged to understand more about how opioids exert their effects in the body and brain; the consequences of opioid use regarding physical dependence, withdrawal, and craving; how we might best treat opioid use disorder (OUD) and address risk for opioid-related overdose; and how opioids may intersect with other clinical conditions to produce unique challenges.

    Edited by Kelly E. Dunn, The Oxford Handbook of Opioids and Opioid Use Disorder synthesizes research across the spectrum, and establishes a foundational knowledge regarding historical and current epidemiological trends, neurobiological and genetic contributors to opioid effects and OUD, and core elements of opioid use such as withdrawal and craving. It provides specific information and guidance regarding opioid treatment paradigms, including chapters on specific pharmacotherapies as well as treatment approaches, and discusses considerations for special clinical populations. An overview of these respective issues is provided across 38 chapters, which outline the history and science of these topics alongside clinical considerations and case examples.

    Written by expert bench scientists, epidemiologists, clinical trial interventionists, medical practitioners, and harm reduction specialists, this handbook will serve as a comprehensive guide for practitioners, policymakers, students, and researchers who wish to achieve a better understanding of the complex world of opioid and OUD practice and science.

    More

    Table of Contents:

    Chapter 1: Historical Events that Shaped Contemporary Opioid Trends
    Kelly E. Dunn
    Chapter 2: Epidemiology of Opioid Use and Smoking, Alcohol, and Polysubstance Use Among Persons Using Opioids
    Maria A. Parker and Whitney S. Cordoba-Grueso
    Chapter 3 Opioid Use Disorder: Diagnostic History and Current Understanding
    Orrin D. Ware and Kelly E. Dunn
    Chapter 4: Access to Treatment for Opioid Use Disorder
    Brendan Saloner and Jason Gibbons
    Chapter 5: The Current Status of Medical Student Education on Opioids
    Oluwole Jegede, Peter J. Na, Ismene Petrakis, and Srinivas B. Muvvala
    Chapter 6: The Neurobiology of Opioid Use
    Shailesh N. Khatri, Erin E. Maher, Emma O. Bondy, and Cassandra D. Gipson
    Chapter 7: Genetic Influences in Opioid Use Disorder
    Jill Rabinowitz and Brion Maher
    Chapter 8: The Opioid Withdrawal Syndrome: Presentation, Measurement, and Management
    Kelly E. Dunn, Cecilia Bergeria, Orrin D. Ware, Eric C. Strain
    Chapter 9: Neonatal Abstinence Syndrome
    Sarah H. Heil, Heidi S. Melbostad, and Leigh-Anne Cioffredi
    Chapter 10: Opioid Craving: Understanding Its Measurement, Mechanisms, and Treatment
    Cecilia Bergeria and Brandon Park
    Chapter 11: Opioids and Cognition
    Bethea A. Kleykamp, Shannon B. Clarke, and Shauna P. Acquavita
    Chapter 12: Opioid Effects on Sleep: Review of the Literature and Consideration of the Hypothalamic-Pituitary-Adrenal Axis as a Relevant Mechanism
    Jennifer D. Ellis, Chung Jung Mun, and Patrick H. Finan
    Chapter 13: Fentanyl
    Kelly E. Dunn, H. Elizabeth Bird, and Caitlyn J. Durgin
    Chapter 14: Tramadol
    Kelly E. Dunn, Judy Ashworth, and Eric C. Strain
    Chapter 15: Kratom (Mitragyna speciosa): Pharmacology and Use of a Naturally Occurring Atypical Opioid
    Kirsten E. Smith, Oliver Grundmann, Marc T. Swogger, and Albert Garcia-Romeu
    Chapter 16: Ibogaine and Noribogaine
    Deborah C. Mash and Michael Karukin
    Chapter 17: Abuse Deterrent and Sustained Release Opioid Formulations
    Rachel R. Luba, Sandra D. Comer, and Edward V. Nunes
    Chapter 18: Methadone
    Jonathan R. Buchholz, Molly Kalmoe, Justin Stamschror, and Andrew J. Saxon
    Chapter 19: Buprenorphine
    Eric C. Strain and Andrew Gaddis
    Chapter 20: Naltrexone
    Marina Tsoy-Podosenin and Evgeny Krupitsky
    Chapter 21: Clonidine
    Mark S. Gold and Kenneth Blum
    Chapter 22: Lofexidine
    Charles W. Gorodetzky, Kristen L. Gullo, and Marc Fishman
    Chapter 23: Injectable Opioid Treatment
    Eugenia Oviedo-Joekes
    Chapter 24: Long-Term Treatment of Opioid Use Disorder With Medications
    Aaron S. Wolfgang, Melissa B. Weimer, Peter J. Na, David A. Fiellin, and Srinivas B. Muvvala
    Chapter 25: Supervised Withdrawal Opioid Use Disorder Treatments
    Kelly E. Dunn and Andrew S. Huhn
    Chapter 26: Psychosocial Treatment Methods
    Jessica M. Peirce, Denis G. Antoine, Alexis S. Hammond, and Michael S. Kidorf
    Chapter 27: Behavioral and Self-directed Treatments for Opioid Use Disorder
    Wendy Insalaco and J. Gregory Hobelmann
    Chapter 28: Contingency Management Treatment of Opioid Use Disorder
    August F. Holtyn, Forrest Toegel, and Matthew D. Novak
    Chapter 29: Treating Opioid Use During Pregnancy and Postpartum Life Phases
    Hendrée E. Jones
    Chapter 30: Pharmacy-Based Treatment Options for Opioid Use Disorder
    Ali Cheetham and Suzanne Nielsen
    Chapter 31: Opioid Overdose: Mechanisms and Naloxone
    Jermaine D. Jones, Rachel R. Luba, Mudassir Mumtaz, and Felipe Castillo
    Chapter 32: Opioid Overdose: Intervention Strategies
    Laura Brandt
    Chapter 33: Supervised Consumption Services
    Jeanette Bowles, Meaghan Thumath, Gillian Kolla, Zoe Dodd, Jaime Arredondo Sanchez Lira, Frank Crichlow, and Leo Beletsky
    Chapter 34: Psychiatric Comorbidities Among Persons Who Are Using Opioids
    R. Kathryn McHugh
    Chapter 35: Sex as a Biological Variable and Gender as a Social Construct in the Treatment of Opioid Use Disorder
    Andrew S. Huhn
    Chapter 36: Challenges of Opioid Use Disorder in Rural Settings
    Stacey C. Sigmon and Jennifer R. Havens
    Chapter 37: Differences Between Those Engaged in Heroin Use and Non-Prescribed Opioid Use
    Ty S. Schepis, Bowie Duncan, and Katherine Vrotsos
    Chapter 38: The Impact of Opioid Use Disorder on Families and Children
    Erin L. Winstanley, Amanda Newhouse, and Kari-Beth Law

    More